Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.

Stanek O, Linhartova I, Majlessi L, Leclerc C, Sebo P.

Mol Biotechnol. 2012 Jul;51(3):221-32. doi: 10.1007/s12033-011-9459-6.

PMID:
22006508
2.

Antigen-conjugated human IgE induces antigen-specific T cell tolerance in a humanized mouse model.

Baravalle G, Greer AM, LaFlam TN, Shin JS.

J Immunol. 2014 Apr 1;192(7):3280-8. doi: 10.4049/jimmunol.1301751. Epub 2014 Mar 7.

3.

Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.

Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S.

J Immunol. 2011 Jan 15;186(2):1218-27. doi: 10.4049/jimmunol.1000808. Epub 2010 Dec 13.

4.

Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells.

Dong H, Stanek O, Salvador FR, Länger U, Morillon E, Ung C, Sebo P, Leclerc C, Majlessi L.

Mucosal Immunol. 2013 May;6(3):522-34. doi: 10.1038/mi.2012.92. Epub 2012 Oct 3.

PMID:
23032790
5.

Expression of a versatile DC-targeting fusion protein using an Adenovirus expression system.

Pillay S, Patterson S.

Protein Expr Purif. 2012 Aug;84(2):270-9. doi: 10.1016/j.pep.2012.06.004. Epub 2012 Jun 21.

PMID:
22728768
6.

A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.

Arribillaga L, Durantez M, Lozano T, Rudilla F, Rehberger F, Casares N, Villanueva L, Martinez M, Gorraiz M, Borrás-Cuesta F, Sarobe P, Prieto J, Lasarte JJ.

Biomed Res Int. 2013;2013:864720. doi: 10.1155/2013/864720. Epub 2013 Sep 5.

7.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
8.
9.

Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.

Ejaz A, Ammann CG, Werner R, Huber G, Oberhauser V, Hörl S, Schimmer S, Dittmer U, von Laer D, Stoiber H, Bánki Z.

PLoS One. 2012;7(9):e45102. doi: 10.1371/journal.pone.0045102. Epub 2012 Sep 17.

10.

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.

Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.

J Immunol. 2008 Mar 1;180(5):3201-9.

11.

Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.

Cruz LJ, Rosalia RA, Kleinovink JW, Rueda F, Löwik CW, Ossendorp F.

J Control Release. 2014 Oct 28;192:209-18. doi: 10.1016/j.jconrel.2014.07.040. Epub 2014 Jul 25.

PMID:
25068703
12.

Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.

Kreiter S, Selmi A, Diken M, Sebastian M, Osterloh P, Schild H, Huber C, Türeci O, Sahin U.

J Immunol. 2008 Jan 1;180(1):309-18. Erratum in: J Immunol. 2012 Sep 1;189(5):2682.

13.
15.

Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo.

Flamar AL, Zurawski S, Scholz F, Gayet I, Ni L, Li XH, Klechevsky E, Quinn J, Oh S, Kaplan DH, Banchereau J, Zurawski G.

J Immunol. 2012 Sep 1;189(5):2645-55. doi: 10.4049/jimmunol.1102390. Epub 2012 Aug 3.

16.

Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.

Adams EW, Ratner DM, Seeberger PH, Hacohen N.

Chembiochem. 2008 Jan 25;9(2):294-303. doi: 10.1002/cbic.200700310.

17.

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.

Ramakrishna V, Treml JF, Vitale L, Connolly JE, O'Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ.

J Immunol. 2004 Mar 1;172(5):2845-52.

18.

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43.

19.

Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Bates JT, Graff AH, Phipps JP, Grayson JM, Mizel SB.

J Immunol. 2011 Jun 1;186(11):6255-62. doi: 10.4049/jimmunol.1001855. Epub 2011 Apr 22.

20.

Supplemental Content

Support Center